NICE blocks Erbitux for head and neck cancer
May 17, 2007Merck's targeted cancer drug Erbitux has been rejected by NICE for use against head and neck cancer.The Watchdog's Final Appraisal …
Gates Foundation could rival pharma, analysts warn
May 15, 2007Sales and Marketing Gates Foundation, HIV, TB, vaccines
The pharmaceutical industry could suffer a blow to its reputation, and could even suffer commercially, if it fails to appreciate …
GP prescribing costs contained in ’06
May 15, 2007Sales and Marketing
Pharma revenues from primary care prescribing in England edged up three per cent in 2006, with fewer GP-led product launches …
‘Research must be nurtured,’ says industry
May 15, 2007Research and Development
Nearly 1,000 potential future medicines are in the pipelines of some 50 companies operating in the UK, a survey by …
Date for NICE court showdown announced
May 14, 2007Sales and Marketing
NICE's decision to block access to Alzheimer's drugs will be put under legal scrutiny on 25 June when a much …
NHS managers praise Blair’s record
May 10, 2007News of Tony Blair's resignation as Prime Minister has been greeted with a tribute from NHS managers.Blair has announced he …
NICE attacks ‘flawed and inaccurate’ cancer report
May 10, 2007Andrew Dillon, the chief executive of NICE has hit out at a new report which says the UK has the …
Leapfrog leads Adventis’ online drive
May 10, 2007Medical Communications digi
Leapfrog has expanded its multimedia division as part of an investment drive into cutting-edge technologies by its parent company, marketing …
Novartis buys rights to smoking vaccine
May 10, 2007Research and Development, Sales and Marketing
Smokers who are addicted to the nicotine in their daily cigarettes could soon receive a vaccine to help them kick …
AstraZeneca’s latest purchase fails to impress investors
May 10, 2007Research and Development, Sales and Marketing
AstraZeneca has entered the lucrative vaccine market and gained a range of potential new biologic products with the $15.6 billion …
The End of the Junket?
May 10, 2007Medical Communications, Sales and Marketing ethics
Once considered a perk of the job by some doctors, trips to glamorous locations paid for by pharma companies are …
Scottish Sprycel approval turns spotlight on NICE
May 9, 2007Sales and Marketing Scotland
The Scottish Medicines Consortium has approved BMS leukaemia drug Sprycel, but patients in England could face a substantial wait for …
Take NHS away from politicians, say doctors
May 9, 2007Doctors have put together a list of radical reforms they say will stop the government undermining the NHS in England …
Product news roundup from Datamonitor
May 9, 2007Research and Development, Sales and Marketing
Additional indication for Pfizer's FragminThe FDA has approved a new indication for blood clot drug Fragmin to treat symptomatic venous …
EMEA gives extension to Celebrex’s European arthritis licence
May 4, 2007Sales and Marketing
Pfizer's Celebrex has received European approval for a new indication to treat arthritis pain and inflammation.The company will look to …
NHS must prepare for health impact of global warming, say experts
May 4, 2007Sales and Marketing
The British public and the NHS need to adapt to climate change and the new risks to health it will …
Herceptin approved for new breast cancer combination
May 4, 2007Sales and Marketing
Herceptin has gained approval in Europe for use in combination with aromatase inhibitor drugs.Herceptin and aromatase inhibitors each block hormones …
Generic attacks dent Sanofi-Aventis
May 4, 2007Sales and Marketing generics
Some of Sanofi-Aventis' biggest selling drugs came under assault from generic competitors in the first part of 2007, holding back …
Animal rights extremists arrested in nationwide raids
May 2, 2007Sales and Marketing animal activists
More than 30 suspected animal rights extremists have been arrested in raids across the UK and Europe in one of …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
